Experience

RECIPE Chemicals + Instruments GmbH

• Germany
• Medical Device
• 1 - 100 Employee

• CEO

  • Jun 2017 - Present

  Development, manufacturing and sales of HPLC, LCMS- and ICP-MS-based in-vitro diagnostica.For better medical treatment, quality of life and healthy aging, see:www.recipe.de Development, manufacturing and sales of HPLC, LCMS- and ICP-MS-based in-vitro diagnostica.For better medical treatment, quality of life and healthy aging, see:www.recipe.de



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Sr Director

  • Jun 2013 - May 2017

  Ph3a/3b/4 clinical development and clinical lead FDA approval of Pfizer's opioid portfolio (i.e., Embeda, Troxyca ER) Ph3a/3b/4 clinical development and clinical lead FDA approval of Pfizer's opioid portfolio (i.e., Embeda, Troxyca ER)



AbbVie

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Sr Medical Director

  • Nov 2011 - Jun 2013

  Ph2 clinical development of early pain assets (i.e., TRPV1, H3 antagonist), Ph4 life-cycle development HIV anti-infectives Ph2 clinical development of early pain assets (i.e., TRPV1, H3 antagonist), Ph4 life-cycle development HIV anti-infectives



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Director

  • Jun 2008 - Nov 2011

  Late-stage Ph3a (pivotal) clinical development of anti-NGF (tanezumab) in LBP, OA and visceral indications Late-stage Ph3a (pivotal) clinical development of anti-NGF (tanezumab) in LBP, OA and visceral indications



Grünenthal Group

• Germany
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Global Clinical Lead

  • Jan 2002 - Jun 2008

  Ph3a/3b/4 clinical development of pediatric formulation for tramadol, cancer pain programs for transdermal buprenorphine and tapentadol Ph3a/3b/4 clinical development of pediatric formulation for tramadol, cancer pain programs for transdermal buprenorphine and tapentadol



Accenture

• Ireland
• Business Consulting and Services
• 700 & Above Employee

• Manager Products/Pharma

  • Dec 2000 - Dec 2001

  Change management (e.g., Redirecting Medical at Bayer AG) Change management (e.g., Redirecting Medical at Bayer AG)



RWTH Aachen University

• Germany
• Research Services
• 700 & Above Employee

• Resident/Clinical Pharmacologist

  • Jan 1995 - Dec 2000

  Principal- and co-investigator Ph1/2 clinical studies, i.e., single/repeated/ascending dose finding Principal- and co-investigator Ph1/2 clinical studies, i.e., single/repeated/ascending dose finding



Ludwig-Maximilians-Universität München

• Germany
• Higher Education
• 700 & Above Employee

• Resident/Internal Medicine

  • Oct 1990 - Dec 1994

  District Hospital of Traunstein, cardiology, gastro-enterology, oncology, clinical chemistry District Hospital of Traunstein, cardiology, gastro-enterology, oncology, clinical chemistry



Bundeswehr (German Federal Armed Forces)

• Germany
• Defense and Space Manufacturing
• 700 & Above Employee

• Postdoc/Staff Scientist Pharmacology

  • Oct 1988 - Sep 1990

  Development of pre-clinical models for neuroactive compounds (i.e., AChE antagonists); development of GC/MS applications for stereo-isomer specific analyses of neuroactive compounds. In cooperation with Postdoc at LMU Munich. Development of pre-clinical models for neuroactive compounds (i.e., AChE antagonists); development of GC/MS applications for stereo-isomer specific analyses of neuroactive compounds. In cooperation with Postdoc at LMU Munich.